Gen-Probe buys GTI Diagnostics for $53 million

Gen-Probe Inc. (NSDQ:GPRO) bought Waukesha,Wis.-based GTI Diagnostics in a self-funded $53 million cash deal.

The acquisition allows the San Diego-based company to expand its transplant diagnostics business, according to Gen-Probe.

GTI develops medical diagnostic assays for the transplantation, blood bank and specialty coagulation markets. Its human leukocyte antigen, or HLA, antibody detection products are already sold by Gen-Probe under the Lifecodes brand, but the company has also commercialized a number of other HLA-related testing products, including serological typing trays, enzyme immunoassays and molecular typing products for donor-recipient matching,according to Gen-Probe.

GTI was owned by Cleveland-based private equity firm the Riverside Co. and investors, including the company’s founders.

MassDevice Staff

The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.

about | more